At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double Blind, Single Dose, Two Treatment, Two Period Crossover Pharmacokinetic Study Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®) in Healthy Volunteers
In Brief
A Phase 2 clinical trial evaluating Menthae piperitae aetheroleum/peppermint oil (enteric coated capsule) and Menthae piperitae aetheroleum/peppermint oil (colon-targeted-delivery capsule) for Irritable Bowel Syndrome and 3 related conditions. Completed, enrolled 8 participants across 1 site.
Detailed Summary
This is a pilot study to compare the relative bioavailability between two peppermint oil formulations, namely a ileocolonic release peppermint oil and an small intestinal release peppermint oil (Tempocol®). This study is conducted as part of a future multicenter randomized controlled trial that will assess the therapeutic effect of the new peppermint oil formulation in IBS patients.
Study Details
Timeline
Interventions
Peppermint oil capsule available as an over the counter prescription drug on the Dutch market.
Peppermint oil capsule with a coating developed according to the ColoPulse® technology, ensuring a pulsatile and therefore slower release in a lower part of the intestinal tract compared to Tempocol, namely in the (ileo-)colonic region.